A genome-wide scan for common variants affecting the rate of age-related cognitive decline

Neurobiology of Aging

Volumn 33, Issue 5, 2012, Pages 1017.e1-1017.e15

  De Jager, Philip L ^a,b,c   Shulman, Joshua M ^a,b,c   Chibnik, Lori B ^a,b,c   Keenan, Brendan T ^a,c   Raj, Towfique ^a,b   Wilson, Robert S ^d   Yu, Lei ^d   Leurgans, Sue E ^d   Tran, Dong ^a,b,c   Aubin, Cristin ^a,b,c   Anderson, Christopher D ^c,e   Biffi, Alessandro ^c,e   Corneveaux, Jason J ^f   Huentelman, Matthew J ^f   Rosand, Jonathan ^b,c,e   Daly, Mark J ^b,c,e   Myers, Amanda J ^g,h   Reiman, Eric M ^f,i,j   Bennett, David A ^d   Evans, Denis A ^d,k  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF SOUTH FLORIDA   (United States)

ⁱ UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^k RUSH UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Alzheimer's disease; Cognitive decline; Genetic risk score; Genome wide association study

Indexed keywords

AGE RELATED COGNITIVE DECLINE; AGED; ALZHEIMER DISEASE; APOE GENE; ARTICLE; COGNITION; COGNITIVE DEFECT; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MTFR1 GENE; PDE7A GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE TRAIT LOCUS;

EID: 85018059449     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.09.033     Document Type: Article

References (81)

1. Arvanitakis Z., Wilson R.S., Bienias J.L., Evans D.A., Bennett D.A. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch. Neurol. 2004, 61:661-666.
2. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
3. Bennett D., Schneider J., Arvanitakis Z., Kelly J., Aggarwal N., Shah R., Wilson R. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006, 66:1837-1844.
4. Bennett D., Schneider J., Wilson R., Bienias J., Berry-Kravis E., Arnold S. Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people. J. Neurol. Neurosurg. Psychiatry 2005, 76:1194-1199.
5. Bennett D.A., Schneider J.A., Aggarwal N.T., Arvanitakis Z., Shah R.C., Kelly J.F., Fox J.H., Cochran E.J., Arends D., Treinkman A.D., Wilson R.S. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology 2006, 27:169-176.
6. Bennett D.A., Schneider J.A., Buchman A.S., Mendes de Leon C., Bienias J.L., Wilson R.S. The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology 2005, 25:163-175.
7. Bennett D.A., Wilson R.S., Schneider J.A., Evans D.A., Beckett L.A., Aggarwal N.T., Barnes L.L., Fox J.H., Bach J. Natural history of mild cognitive impairment in older persons. Neurology 2002, 59:198-205.
8. Bertram L., Tanzi R.E. Genome-wide association studies in Alzheimer's disease. Hum. Mol. Genet. 2009, 18:R137-R145.
9. Bienias J.L., Beckett L.A., Bennett D.A., Wilson R.S., Evans D.A. Design of the Chicago Health and Aging Project (CHAP). J. Alzheimers Dis. 2003, 5:349-355.
10. Biffi A., Anderson C.D., Desikan R.S., Sabuncu M., Cortellini L., Schmansky N., Salat D., Rosand J. Genetic variation and neuroimaging measures in Alzheimer disease. Arch. Neurol. 2010, 67:677-685. Alzheimer's Disease Neuroimaging Initiative (ADNI).
11. Bishop N.A., Lu T., Yankner B.A. Neural mechanisms of ageing and cognitive decline. Nature 2010, 464:529-535.
12. Chibnik L.B., Shulman J.M., Leurgans S.E., Schneider J.A., Wilson R.S., Tran D., Aubin C., Buchman A.S., Heward C.B., Myers A.J., Hardy J.A., Huentelman M.J., Corneveaux J.J., Reiman E.M., Evans D.A., Bennett D.A., De Jager P.L. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann. Neurol. 2011, 69:560-569.
13. Cho D.H., Nakamura T., Lipton S.A. Mitochondrial dynamics in cell death and neurodegeneration. Cell. Mol. Life Sci. 2010, 67:3435-3447.
14. Cockburn I.A., Mackinnon M.J., O'Donnell A., Allen S.J., Moulds J.M., Baisor M., Bockarie M., Reeder J.C., Rowe J.A. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:272-277.
15. Croxson S.C., Jagger C. Diabetes and cognitive impairment: a community-based study of elderly subjects. Age Ageing 1995, 24:421-424.
16. De Jager P., Jia X., Wang J., de Bakker P., Ottoboni L., Aggarwal N., Piccio L., Raychaudhuri S., Tran D., Aubin C., Briskin R., Romano S., Consortium I.M.G., Baranzini S., McCauley J., Pericak-Vance M., Haines J., Gibson R., Naeglin Y., Uitdehaag B., Matthews P., Kappos L., Polman C., McArdle W., Strachan D., Evans D., Cross A., Daly M., Compston A., Sawcer S., Weiner H., Hauser S., Hafler D., Oksenberg J. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 2009, 41:776-782.
17. Desmond D.W., Moroney J.T., Paik M.C., Sano M., Mohr J.P., Aboumatar S., Tseng C.L., Chan S., Williams J.B., Remien R.H., Hauser W.A., Stern Y. Frequency and clinical determinants of dementia after ischemic stroke. Neurology 2000, 54:1124-1131.
18. Desmond D.W., Tatemichi T.K., Paik M., Stern Y. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch. Neurol. 1993, 50:162-166.
19. Dong H., Zitt C., Auriga C., Hatzelmann A., Epstein P.M. Inhibition of PDE3, PDE4 and PDE7 potentiates glucocorticoid-induced apoptosis and overcomes glucocorticoid resistance in CEM T leukemic cells. Biochem. Pharmacol. 2010, 79:321-329.
20. Eichner J.E., Dunn S.T., Perveen G., Thompson D.M., Stewart K.E., Stroehla B.C. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am. J. Epidemiol. 2002, 155:487-495.
21. Evans D.A., Bennett D.A., Wilson R.S., Bienias J.L., Morris M.C., Scherr P.A., Hebert L.E., Aggarwal N., Beckett L.A., Joglekar R., Berry-Kravis E., Schneider J. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch. Neurol. 2003, 60:185-189.
22. Feskens E.J., Havekes L.M., Kalmijn S., de Knijff P., Launer L.J., Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ 1994, 309:1202-1206.
23. Grodstein F., Chen J., Wilson R.S., Manson J.E., Study N.H. Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 2001, 24:1060-1065.
24. Haan M.N., Shemanski L., Jagust W.J., Manolio T.A., Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 1999, 282:40-46.
25. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., Jones N., Thomas C., Stretton A., Morgan A.R., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Love S., Kehoe P.G., Hardy J., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., Schürmann B., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frölich L., Hampel H., Hüll M., Rujescu D., Goate A.M., Kauwe J.S.K., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Mühleisen T.W., Nöthen M.M., Moebus S., Jöckel K.-H., Klopp N., Wichmann H.-E., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Holmans P.A., O'Donovan M., Owen M.J., Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 2009, 41:1088-1093.
26. Henderson A.S., Easteal S., Jorm A.F., Mackinnon A.J., Korten A.E., Christensen H., Croft L., Jacomb P.A. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet 1995, 346:1387-1390.
27. Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.-C., Carrasquillo M.M., Abraham R., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Jones N., Stretton A., Thomas C., Richards A., Ivanov D., Widdowson C., Chapman J., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Beaumont H., Warden D., Wilcock G., Love S., Kehoe P.G., Hooper N.M., Vardy E.R.L.C., Hardy J., Mead S., Fox N.C., Rossor M., Collinge J., Maier W., Jessen F., Rüther E., Schürmann B., Heun R., Kölsch H., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frölich L., Hampel H., Gallacher J., Hüll M., Rujescu D., Giegling I., Goate A.M., Kauwe J.S.K., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Mühleisen T.W., Nöthen M.M., Moebus S., Jöckel K.-H., Klopp N., Wichmann H.-E., Pankratz V.S., Sando S.B., Aasly J.O., Barcikowska M., Wszolek Z.K., Dickson D.W., Graff-Radford N.R., Petersen R.C., van Duijn C.M., Breteler M.M.B., Ikram M.A., DeStefano A.L., Fitzpatrick A.L., Lopez O., Launer L.J., Seshadri S., Berr C., Campion D., Epelbaum J., Dartigues J.-F., Tzourio C., Alpérovitch A., Lathrop M., Feulner T.M., Friedrich P., Riehle C., Krawczak M., Schreiber S., Mayhaus M., Nicolhaus S., Wagenpfeil S., Steinberg S., Stefansson H., Stefansson K., Snædal J., Björnsson S., Jonsson P.V., Chouraki V., Genier-Boley B., Hiltunen M., Soininen H., Combarros O., Zelenika D., Delepine M., Bullido M.J., Pasquier F., Mateo I., Frank-Garcia A., Porcellini E., Hanon O., Coto E., Alvarez V., Bosco P., Siciliano G., Mancuso M., Panza F., Solfrizzi V., Nacmias B., Sorbi S., Bossù P., Piccardi P., Arosio B., Annoni G., Seripa D., Pilotto A., Scarpini E., Galimberti D., Brice A., Hannequin D., Licastro F., Jones L., Holmans P.A., Jonsson T., Riemenschneider M., Morgan K., Younkin S.G., Owen M.J., O'Donovan M., Amouyel P., Williams J. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 2011, 43:429-435.
28. Hyman B.T., Gomez-Isla T., Briggs M., Chung H., Nichols S., Kohout F., Wallace R. Apolipoprotein E and cognitive change in an elderly population. Ann. Neurol. 1996, 40:55-66.
29. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., Belmont J.W., Boudreau A., Hardenbol P., Leal S.M., Pasternak S.M., Wheeler D.A., Willis T.D., Yu F., Yang H., Zeng C., Gao Y., Hu H., Hu H., Li C., Lin W., Liu S., Pan H., Tang X., Wang J., Wang J., Yu J., Zhang B., Zhang B., Zhao H., Zhou J., Gabriel S.B., Barry R., Blumenstiel B., Camargo A., Defelice M., Faggart M., Defelice M., Gupta S., Moore J., Nguyen H., Onofrio R.C., Parkin M., Roy J., Stahl E., Winchester E., Ziaugra L., Altshuler D., Shen Y., Yao Z., Huang W., Chu X., He Y., Jin L., Liu Y., Sun W., Wang H., Wang Y., Xiong X., Xu L., Waye M.M., Tsui S.K., Xue H., Wong J.T., Galver L.M., Fan J.B., Gunderson K., Murray S.S., Oliphant A.R., Chee M.S., Montpetit A., Chagnon F., Ferretti V., Leboeuf M., Olivier J.F., Phillips M.S., Roumy S., Sallee C., Verner A., Hudson T.J., Kwok P.Y., Cai D., Koboldt D.C., Miller R.D., Pawlikowska L., Taillon-Miller P., Xiao M., Tsui L.C., Mak W., Song Y.Q., Tam P.K., Nakamura Y., Kawaguchi T., Kitamoto T., Morizono T., Nagashima A., Ohnishi Y., Sekine A., Tanaka T., Tsunoda T., Deloukas P., Bird C.P., Delgado M., Dermitzakis E.T., Gwilliam R., Hunt S., Morrison J., Powell D., Stranger B.E., Whittaker P., Bentley D.R., Daly M.J., de Bakker P.I., Barrett J., Chretien Y.R., Maller J., McCarroll S., Patterson N., Pe'er I., Price A., Purcell S., Richter D.J., Sabeti P., Saxena R., Schaffner S.F., Sham P.C., Varilly P., Stein L.D., Krishnan L., Smith A.V., Tello-Ruiz M.K., Thorisson G.A., Chakravarti A., Chen P.E., Cutler D.J., Kashuk C.S., Lin S., Abecasis G.R., Guan W., Li Y., Munro H.M., Qin Z.S., Thomas D.J., McVean G., Auton A., Bottolo L., Cardin N., Eyheramendy S., Freeman C., Marchini J., Myers S., Spencer C., Stephens M., Donnelly P., Cardon L.R., Clarke G., Evans D.M., Morris A.P., Weir B.S., Mullikin J.C., Sherry S.T., Feolo M., Skol A., Zhang H., Matsuda I., Fukushima Y., Macer D.R., Suda E., Rotimi C.N., Adebamowo C.A., Ajayi I., Aniagwu T., Marshall P.A., Nkwodimmah C., Royal C.D., Leppert M.F., Dixon M., Peiffer A., Qiu R., Kent A., Kato K., Niikawa N., Adewole I.F., Knoppers B.M., Foster M.W., Clayton E.W., Watkin J., Muzny D., Nazareth L., Sodergren E., Weinstock G.M., Yakub I., Birren B.W., Wilson R.K., Fulton L.L., Rogers J., Burton J., Carter N.P., Clee C.M., Griffiths M., Jones M.C., McLay K., Plumb R.W., Ross M.T., Sims S.K., Willey D.L., Chen Z., Han H., Kang L., Godbout M., Wallenburg J.C., L'Archeveque P., Bellemare G., Saeki K., An D., Fu H., Li Q., Wang Z., Wang R., Holden A.L., Brooks L.D., McEwen J.E., Guyer M.S., Wang V.O., Peterson J.L., Shi M., Spiegel J., Sung L.M., Zacharia L.F., Collins F.S., Kennedy K., Jamieson R., Stewart J., Fu H., Li Q., Wang Z., Wang R., Holden A.L., Brooks L.D., McEwen J.E., Guyer M.S., Wang V.O., Peterson J.L., Shi M., Spiegel J., Sung L.M., Zacharia L.F., Collins F.S., Kennedy K., Jamieson R., Stewart J. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861. International HapMap Consortium.
30. Israely I., Costa R.M., Xie C.W., Silva A.J., Kosik K.S., Liu X. Deletion of the neuron-specific protein delta-catenin leads to severe cognitive and synaptic dysfunction. Curr. Biol. 2004, 14:1657-1663.
31. Johnson A.D., Handsaker R.E., Pulit S.L., Nizzari M.M., O'Donnell C.J., de Bakker P.I. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008, 24:2938-2939.
32. Jonker C., Schmand B., Lindeboom J., Havekes L.M., Launer L.J. Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch. Neurol. 1998, 55:1065-1069.
33. Kadoshima-Yamaoka K., Murakawa M., Goto M., Tanaka Y., Inoue H., Murafuji H., Nagahira A., Hayashi Y., Nagahira K., Miura K., Nakatsuka T., Chamoto K., Fukuda Y., Nishimura T. ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-gamma production by mouse activated T lymphocytes. Immunol. Lett. 2009, 122:193-197.
34. Kim J.S., Han S.R., Chung S.W., Kim B.S., Lee K.S., Kim Y.I., Yang D.W., Kim K.S., Kim J.W. The apolipoprotein E epsilon4 haplotype is an important predictor for recurrence in ischemic cerebrovascular disease. J. Neurol. Sci. 2003, 206:31-37.
35. Laird N.M., Ware J.H. Random-effects models for longitudinal data. Biometrics 1982, 38:963-974.
36. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fiévet N., Barberger-Gateau P., Engelborghs S., De Deyn P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O., de Pancorbo M.M., Lendon C., Dufouil C., Jaillard C., Leveillard T., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossù P., Piccardi P., Annoni G., Seripa D., Galimberti D., Hannequin D., Licastro F., Soininen H., Ritchie K., Blanché H., Dartigues J.F., Tzourio C., Gut I., Van Broeckhoven C., Alpérovitch A., Lathrop M., Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 2009, 41:1094-1099. European Alzheimer's Disease Initiative Investigators.
37. Launer L.J., Petrovitch H., Ross G.W., Markesbery W., White L.R. AD brain pathology: vascular origins?. Results from the HAAS autopsy study. Neurobiol. Aging 2008, 29:1587-1590.
38. Lucin K.M., Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little?. Neuron 2009, 64:110-122.
39. Martinez-Vicente M., Cuervo A.M. Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol. 2007, 6:352-361.
40. McCarron M.O., Delong D., Alberts M.J. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology 1999, 53:1308-1311.
41. McClearn G.E., Johansson B., Berg S., Pedersen N.L., Ahern F., Petrill S.A., Plomin R. Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 1997, 276:1560-1563.
42. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
43. McQueen M.B., Bertram L., Lange C., Becker K.D., Albert M.S., Tanzi R.E., Blacker D. Exploring candidate gene associations with neuropsychological performance. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B:987-991.
44. Medina M., Marinescu R.C., Overhauser J., Kosik K.S. Hemizygosity of delta-catenin (CTNND2) is associated with severe mental retardation in cri-du-chat syndrome. Genomics 2000, 63:157-164.
45. Miró X., Pérez-Torres S., Palacios J.M., Puigdomènech P., Mengod G. Differential distribution of cAMP-specific phosphodiesterase 7A mRNA in rat brain and peripheral organs. Synapse 2001, 40:201-214.
46. Monticone M., Tonachini L., Tavella S., Degan P., Biticchi R., Palombi F., Puglisi R., Boitani C., Cancedda R., Castagnola P. Impaired expression of genes coding for reactive oxygen species scavenging enzymes in testes of Mtfr1/Chppr-deficient mice. Reproduction 2007, 134:483-492.
47. Myers A.J., Gibbs J.R., Webster J.A., Rohrer K., Zhao A., Marlowe L., Kaleem M., Leung D., Bryden L., Nath P., Zismann V.L., Joshipura K., Huentelman M.J., Hu-Lince D., Coon K.D., Craig D.W., Pearson J.V., Holmans P., Heward C.B., Reiman E.M., Stephan D., Hardy J. A survey of genetic human cortical gene expression. Nat. Genet. 2007, 39:1494-1499.
48. Naj A.C., Jun G., Beecham G.W., Wang L.S., Vardarajan B.N., Buros J., Gallins P.J., Buxbaum J.D., Jarvik G.P., Crane P.K., Larson E.B., Bird T.D., Boeve B.F., Graff-Radford N.R., De Jager P.L., Evans D., Schneider J.A., Carrasquillo M.M., Ertekin-Taner N., Younkin S.G., Cruchaga C., Kauwe J.S., Nowotny P., Kramer P., Hardy J., Huentelman M.J., Myers A.J., Barmada M.M., Demirci F.Y., Baldwin C.T., Green R.C., Rogaeva E., St George-Hyslop P., Arnold S.E., Barber R., Beach T., Bigio E.H., Bowen J.D., Boxer A., Burke J.R., Cairns N.J., Carlson C.S., Carney R.M., Carroll S.L., Chui H.C., Clark D.G., Corneveaux J., Cotman C.W., Cummings J.L., DeCarli C., Dekosky S.T., Diaz-Arrastia R., Dick M., Dickson D.W., Ellis W.G., Faber K.M., Fallon K.B., Farlow M.R., Ferris S., Frosch M.P., Galasko D.R., Ganguli M., Gearing M., Geschwind D.H., Ghetti B., Gilbert J.R., Gilman S., Giordani B., Glass J.D., Growdon J.H., Hamilton R.L., Harrell L.E., Head E., Honig L.S., Hulette C.M., Hyman B.T., Jicha G.A., Jin L.-W., Johnson N., Karlawish J., Karydas A., Kaye J.A., Kim R., Koo E.H., Kowall N.W., Lah J.J., Levey A.I., Lieberman A.P., Lopez O.L., Mack W.J., Marson D.C., Martiniuk F., Mash D.C., Masliah E., Mccormick W.C., Mccurry S.M., Mcdavid A.N., McKee A.C., Mesulam M., Miller B.L., Miller C.A., Miller J.W., Parisi J.E., Perl D.P., Peskind E., Petersen R.C., Poon W.W., Quinn J.F., Rajbhandary R.A., Raskind M., Reisberg B., Ringman J.M., Roberson E.D., Rosenberg R.N., Sano M., Schneider L.S., Seeley W., Shelanski M.L., Slifer M.A., Smith C.D., Sonnen J.A., Spina S., Stern R.A., Tanzi R.E., Trojanowski J.Q., Troncoso J.C., Deerlin V.M.V., Vinters H.V., Vonsattel J.P., Weintraub S., Welsh-Bohmer K.A., Williamson J., Woltjer R.L., Cantwell L.B., Dombroski B.A., Beekly D., Lunetta K.L., Martin E.R., Kamboh M.I., Saykin A.J., Reiman E.M., Bennett D.A., Morris J.C., Montine T.J., Goate A.M., Blacker D., Tsuang D.W., Hakonarson H., Kukull W.A., Foroud T.M., Haines J.L., Mayeux R., Pericak-Vance M.A., Farrer L.A., Schellenberg G.D. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 2011, 43:436-441.
49. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001, 357:169-175. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study.
50. Park J.H., Wacholder S., Gail M.H., Peters U., Jacobs K.B., Chanock S.J., Chatterjee N. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat. Genet. 2010, 42:570-575.
51. Pendlebury S.T., Rothwell P.M. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009, 8:1006-1018.
52. Pérez-Torres S., Cortés R., Tolnay M., Probst A., Palacios J.M., Mengod G. Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization. Exp. Neurol. 2003, 182:322-334.
53. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 2006, 38:904-909.
54. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
55. Reijmer Y.D., van den Berg E., Ruis C., Kappelle L.J., Biessels G.J. Cognitive dysfunction in patients with type 2 diabetes. Diabetes/Metab. Res. Rev. 2010, 26:507-519.
56. Reitz C., Brayne C., Mayeux R. Epidemiology of Alzheimer Disease. Nat. Rev. Neurol. 2011, 7:137-152.
57. Reitz C., Tokuhiro S., Clark L.N., Conrad C., Vonsattel J.-P., Hazrati L.-N., Palotás A., Lantigua R., Medrano M., Jiménez-Velázquez I., Vardarajan B., Simkin I., Haines J.L., Pericak-Vance M.A., Farrer L.A., Lee J.H., Rogaeva E., George-Hyslop P.S., Mayeux R. SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk. Ann. Neurol. 2011, 69:47-64.
58. Rhead B., Karolchik D., Kuhn R.M., Hinrichs A.S., Zweig A.S., Fujita P.A., Diekhans M., Smith K.E., Rosenbloom K.R., Raney B.J., Pohl A., Pheasant M., Meyer L.R., Learned K., Hsu F., Hillman-Jackson J., Harte R.A., Giardine B., Dreszer T.R., Clawson H., Barber G.P., Haussler D., Kent W.J. The UCSC Genome Browser database: update 2010. Nucleic Acids Res. 2010, 38:D613-D619.
59. Ross C.A., Poirier M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 2004, 10:S10-S17.
60. Rowe J.A., Moulds J.M., Newbold C.I., Miller L.H. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 1997, 388:292-295.
61. Schneider J.A., Arvanitakis Z., Bang W., Bennett D.A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007, 69:2197-2204.
62. Schneider J.A., Bennett D.A. Where vascular meets neurodegenerative disease. Stroke 2010, 41(Suppl e). S144-S1S6.
63. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., Erdos M.R., Stringham H.M., Chines P.S., Jackson A.U., Prokunina-Olsson L., Ding C.J., Swift A.J., Narisu N., Hu T., Pruim R., Xiao R., Li X.Y., Conneely K.N., Riebow N.L., Sprau A.G., Tong M., White P.P., Hetrick K.N., Barnhart M.W., Bark C.W., Goldstein J.L., Watkins L., Xiang F., Saramies J., Buchanan T.A., Watanabe R.M., Valle T.T., Kinnunen L., Abecasis G.R., Pugh E.W., Doheny K.F., Bergman R.N., Tuomilehto J., Collins F.S., Boehnke M. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345.
64. Seshadri S., Fitzpatrick A.L., Ikram M.A., DeStefano A.L., Gudnason V., Boada M., Bis J.C., Smith A.V., Carassquillo M.M., Lambert J.C., Harold D., Schrijvers E.M.C., Ramirez-Lorca R., Debette S., Longstreth W.T., Janssens A.C.J.W., Pankratz V.S., Dartigues J.F., Hollingworth P., Aspelund T., Hernandez I., Beiser A., Kuller L.H., Koudstaal P.J., Dickson D.W., Tzourio C., Abraham R., Antunez C., Du Y., Rotter J.I., Aulchenko Y.S., Harris T.B., Petersen R.C., Berr C., Owen M.J., Lopez-Arrieta J., Varadarajan B.N., Becker J.T., Rivadeneira F., Nalls M.A., Graff-Radford N.R., Campion D., Auerbach S., Rice K., Hofman A., Jonsson P.V., Schmidt H., Lathrop M., Mosley T.H., Au R., Psaty B.M., Uitterlinden A.G., Farrer L.A., Lumley T., Ruiz A., Williams J., Amouyel P., Younkin S.G., Wolf P.A., Launer L.J., Lopez O.L., van Duijn C.M., Breteler M.M.B., Consortium C. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010, 303:1832-1840.
65. Sonnen J.A., Larson E.B., Crane P.K., Haneuse S., Li G., Schellenberg G.D., Craft S., Leverenz J.B., Montine T.J. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann. Neurol. 2007, 62:406-413.
66. Stern Y. Cognitive reserve. Neuropsychologia 2009, 47:2015-2028.
67. Stranger B.E., Nica A.C., Forrest M.S., Dimas A., Bird C.P., Beazley C., Ingle C.E., Dunning M., Flicek P., Koller D., Montgomery S., Tavaré S., Deloukas P., Dermitzakis E.T. Population genomics of human gene expression. Nat. Genet. 2007, 39:1217-1224.
68. Su A.I., Cooke M.P., Ching K.A., Hakak Y., Walker J.R., Wiltshire T., Orth A.P., Vega R.G., Sapinoso L.M., Moqrich A., Patapoutian A., Hampton G.M., Schultz P.G., Hogenesch J.B. Large-scale analysis of the human and mouse transcriptomes. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:4465-4470.
69. Swan G.E., Carmelli D., Reed T., Harshfield G.A., Fabsitz R.R., Eslinger P.J. Heritability of cognitive performance in aging twins. The National Heart, Lung, and Blood Institute Twin Study. Arch. Neurol. 1990, 47:259-262.
70. Tonachini L., Monticone M., Puri C., Tacchetti C., Pinton P., Rizzuto R., Cancedda R., Tavella S., Castagnola P. Chondrocyte protein with a poly-proline region (CHPPR) is a novel mitochondrial protein and promotes mitochondrial fission. J. Cell. Physiol. 2004, 201:470-482.
71. Troncoso J.C., Zonderman A.B., Resnick S.M., Crain B., Pletnikova O., O'Brien R.J. Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann. Neurol. 2008, 64:168-176.
72. Warsch J.R., Wright C.B. The aging mind: vascular health in normal cognitive aging. J. Am. Geriatr. Soc. 2010, 58(Suppl 2):S319-S324.
73. Willer C.J., Li Y., Abecasis G.R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010, 26:2190-2191.
74. Wilson R., Bienias J., Berry-Kravis E., Evans D., Bennett D. The apolipoprotein E epsilon 2 allele and decline in episodic memory. J. Neurol. Neurosurg., Psychiatry 2002, 73:672-677.
75. Wilson R., Schneider J., Barnes L., Beckett L., Aggarwal N., Cochran E., Berry-Kravis E., Bach J., Fox J., Evans D., Bennett D. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch. Neurol. 2002, 59:1154-1160.
76. Wilson R.S., Barnes L.L., Krueger K.R., Hoganson G., Bienias J.L., Bennett D.A. Early and late life cognitive activity and cognitive systems in old age. J. Int. Neuropsychol. Soc. 2005, 11:400-407.
77. Wilson R.S., Beckett L.A., Barnes L.L., Schneider J.A., Bach J., Evans D.A., Bennett D.A. Individual differences in rates of change in cognitive abilities of older persons. Psychol. Aging 2002, 17:179-193.
78. Wilson R.S., Gilley D.W., Bennett D.A., Beckett L.A., Evans D.A. Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age. Psychol. Aging 2000, 15:18-28.
79. Wilson R.S., Leurgans S.E., Boyle P.A., Schneider J.A., Bennett D.A. Neurodegenerative basis of age-related cognitive decline. Neurology 2010, 75:1070-1078.
80. Wu C., Orozco C., Boyer J., Leglise M., Goodale J., Batalov S., Hodge C.L., Haase J., Janes J., Huss J.W., Su A.I. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 2009, 10:R130.
81. Yang G., McIntyre K.W., Townsend R.M., Shen H.H., Pitts W.J., Dodd J.H., Nadler S.G., McKinnon M., Watson A.J. Phosphodiesterase 7A-deficient mice have functional T cells. J. Immunol. 2003, 171:6414-6420.